Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · IEX Real-Time Price · USD
143.74
+5.92 (4.30%)
At close: Jul 19, 2024, 4:00 PM
143.69
-0.05 (-0.03%)
After-hours: Jul 20, 2024, 12:58 PM EDT

Inspire Medical Systems Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2015
Revenue
660.91624.8407.86233.39115.3882.05
Upgrade
Revenue Growth (YoY)
41.71%53.19%74.75%102.28%40.62%62.18%
Upgrade
Cost of Revenue
101.4596.5866.1233.2817.6213.64
Upgrade
Gross Profit
559.47528.22341.74200.1297.7668.41
Upgrade
Selling, General & Admin
475.59451.96320.69202.62127.8790.47
Upgrade
Research & Development
119.87116.5468.6537.3526.0912.84
Upgrade
Operating Expenses
595.46568.49389.33239.97153.97103.3
Upgrade
Operating Income
-35.99-40.27-47.59-39.85-56.21-34.9
Upgrade
Interest Expense / Income
001.682.132.122.12
Upgrade
Other Expense / Income
-21.94-20.37-5-0.01-1.24-3.81
Upgrade
Pretax Income
-14.05-19.91-44.27-41.97-57.09-33.2
Upgrade
Income Tax
1.681.250.610.070.120.04
Upgrade
Net Income
-15.73-21.15-44.88-42.04-57.2-33.24
Upgrade
Shares Outstanding (Basic)
302928272624
Upgrade
Shares Outstanding (Diluted)
302928272624
Upgrade
Shares Change
1.81%4.38%2.97%4.56%9.53%63.27%
Upgrade
EPS (Basic)
-0.53-0.72-1.60-1.54-2.19-1.40
Upgrade
EPS (Diluted)
-0.53-0.72-1.60-1.54-2.19-1.40
Upgrade
Free Cash Flow
3.291.022.47-24.79-55.5-35.59
Upgrade
Free Cash Flow Per Share
0.110.040.09-0.91-2.13-1.50
Upgrade
Gross Margin
84.65%84.54%83.79%85.74%84.73%83.37%
Upgrade
Operating Margin
-5.45%-6.45%-11.67%-17.07%-48.72%-42.53%
Upgrade
Profit Margin
-2.38%-3.39%-11.00%-18.01%-49.58%-40.52%
Upgrade
Free Cash Flow Margin
0.50%0.16%0.61%-10.62%-48.10%-43.37%
Upgrade
EBITDA
-9.41-15.66-39.69-37.85-53.16-29.69
Upgrade
EBITDA Margin
-1.42%-2.51%-9.73%-16.22%-46.07%-36.18%
Upgrade
Depreciation & Amortization
4.654.252.91.991.811.4
Upgrade
EBIT
-14.05-19.91-42.59-39.84-54.97-31.08
Upgrade
EBIT Margin
-2.13%-3.19%-10.44%-17.07%-47.64%-37.88%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).